Brazil and Nigeria Emerge as Growing Destinations for Indian Pharmaceutical Exports

India's pharmaceutical exports grew 6.5% to USD 20.48 billion during April-November 2025-26, with Brazil and Nigeria emerging as key markets amid global economic uncertainties. Nigeria contributed over 14% to export growth, adding USD 179 million, while Brazil's exports increased by nearly USD 100 million. The US remains the largest destination, accounting for over 31% of exports. Other countries like France, the Netherlands, Canada, Germany, and South Africa also showed steady growth, indicating diversified demand across mature and emerging markets.